MetaCap

Lineage Cell Therapeutics Insider Trades

NYSE: LCTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.994-0.036 (-3.50%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $24.38K
Sales
0 · $0
Shares bought / sold
15.00K / 0
Net activity
Net buying $24,375

Lineage Cell Therapeutics insider activity

Over the last 12 months, Lineage Cell Therapeutics insiders reported 9 transactions on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $24,375 and sold $0 worth of stock, for net insider buying of $24,375. The most recent filing shows Culley Brian M (President and CEO) buying 15,000 shares at $1.63 on Mar 12, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put LCTX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

LCTX insider transactions

Lineage Cell Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Mar 12, 2026Culley Brian MPresident and CEOBuy15,000$24.38KForm 4
Feb 11, 2026Samuel George A. IIIGeneral Counsel and SecretaryTax withholding2,502$4.50KForm 4
Feb 11, 2026Samuel George A. IIIGeneral Counsel and SecretaryOption exercise6,075—Form 4
Feb 11, 2026Culley Brian MPresident and CEOTax withholding12,869$23.16KForm 4
Feb 11, 2026Culley Brian MPresident and CEOOption exercise31,250—Form 4
Dec 19, 2025Culley Brian MPresident and CEOTax withholding334$561.12Form 4
Dec 19, 2025Culley Brian MPresident and CEOAward8,925—Form 4
Dec 19, 2025Samuel George A. IIIGeneral Counsel and SecretaryTax withholding65$109.20Form 4
Dec 19, 2025Samuel George A. IIIGeneral Counsel and SecretaryAward1,735—Form 4
Feb 11, 2025Culley Brian MPresident and CEOTax withholding12,547$8.16KForm 4
Feb 11, 2025Culley Brian MPresident and CEOOption exercise31,249—Form 4
Feb 11, 2025Samuel George A. IIIGeneral CounselTax withholding2,440$1.59KForm 4
Feb 11, 2025Samuel George A. IIIGeneral CounselOption exercise6,076—Form 4
Jan 27, 2025BROADWOOD PARTNERS, L.P. & BROADWOOD CAPITAL INC & BRADSHER NEAL CDirectorBuy0—Form 4
Jan 27, 2025BROADWOOD PARTNERS, L.P. & BROADWOOD CAPITAL INC & BRADSHER NEAL CDirectorBuy7,894,737$6.00MForm 4
Nov 26, 2024Samuel George A. IIIGeneral CounselBuy15,000$9.00KForm 4
Nov 26, 2024Howe Jill AnnChief Financial OfficerBuy15,000$8.85KForm 4
Nov 22, 2024Mulroy Michael H.DirectorBuy40,000$22.64KForm 4
Nov 21, 2024Culley Brian MPresident and CEOBuy40,000$24.00KForm 4
Aug 16, 2024Howe Jill AnnChief Financial OfficerBuy10,500$9.35KForm 4
May 24, 2024Culley Brian MPresident and CEOBuy10,000$10.50KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related